Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Astrocytoma 9Gliosarcoma 8Glioblastoma 8Central Nervous System Neoplasms 8Oligodendroglioma 6Brain Neoplasms 6Glioma 5Unspecified Adult Solid Tumor, Protocol Specific 3Optic Nerve Glioma 3Medulloblastoma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Lymphoma, Non-Hodgkin 2Ependymoma 2Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

romidepsin 12Cyclophosphamide 10fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Gemcitabine 7Bortezomib 7fludarabine 6Lenalidomide 6Filgrastim 6tanespimycin 5Vorinostat 5Magnetic Resonance Spectroscopy 5Etoposide 5Biopsy 5belinostat 4Tacrolimus 4Depsipeptides 4Brentuximab Vedotin 4Whole-Body Irradiation 3Specimen Handling 3Radiotherapy 3Oxaliplatin 3Nivolumab 3Methylprednisolone 3Lactones 3Irinotecan 3Ipilimumab 3Doxorubicin 3Dexamethasone 3Dasatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, T-Cell, Cutaneous × O(6)-benzylguanine × Clear all
NCT00003613 2013-01-11

O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
20 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡